Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Succinylated gelatin for prevention of fluid retention in breast cancer patients receiving docetaxel
NCT04637308Phase 2Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gelofusine + sodium chloride in edema, sponsored by Guangdong Provincial People's Hospital. Started Sep 2019; status: completed.
02
Drugs
gelofusine + sodium chloride
03
Conditions
edema
Beyond the preview
Go deeper on NCT04637308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04637308.